Published Technical Disclosure Archive

Intelligent Cryogenic Needle System with Integrated Technologies

Publication ID: 24-11857239_0008_PTD
Published: November 07, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Intelligent Cryogenic Needle System with Integrated Technologies,” Published Technical Disclosure No. 24-11857239_0008_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857239_0008_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,239.

Summary of the Inventive Concept

A novel cryogenic needle system that integrates AI, IoT, blockchain, and new materials to enhance the precision, safety, and efficacy of cryogenic treatments for dermatological tissues.

Background and Problem Solved

The original cryogenic needle patent has limitations in terms of temperature control, data security, and treatment outcome prediction. The new inventive concept addresses these limitations by incorporating advanced technologies to create a more powerful and efficient system.

Detailed Description of the Inventive Concept

The system consists of a needle probe with at least one needle, a coolant supply system regulated by a valve, and integrated modules for AI-powered temperature control, IoT-enabled temperature sensing, blockchain-based secure data storage, and new material-based thermal insulation. The AI-powered temperature control module adjusts the coolant flow based on real-time temperature data, ensuring precise temperature regulation. The IoT-enabled temperature sensing module transmits real-time temperature data to a remote monitoring system, enabling real-time monitoring and feedback. The blockchain-based secure data storage system stores treatment data securely for future reference, and the new material-based thermal insulation system maintains a consistent temperature profile.

Novelty and Inventive Step

The new claims introduce novel combinations of AI, IoT, blockchain, and new materials with the original cryogenic needle concept, providing a non-obvious and innovative solution for cryogenic treatments. The integration of these technologies enables real-time temperature control, secure data storage, and predictive analytics, which are not achievable with the original patent alone.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include variations in the type of AI algorithm used, the specific IoT protocols employed, or the new materials utilized for thermal insulation. Additionally, the system could be adapted for use in other medical applications beyond dermatological tissues.

Potential Commercial Applications and Market

The intelligent cryogenic needle system has significant commercial potential in the medical aesthetics industry, with potential applications in cosmetic treatments, skin rejuvenation, and tissue remodeling. The system's enhanced precision, safety, and efficacy could lead to increased adoption and market share in these industries.

CPC Classifications

SectionClassGroup
A A61 A61B18/02
A A61 A61B2017/00473
A A61 A61B2018/00029
A A61 A61B2018/00041
A A61 A61B2018/00648
A A61 A61B2018/00714
A A61 A61B2018/00738
A A61 A61B2018/00744
A A61 A61B2018/00779
A A61 A61B2018/00791
A A61 A61B2018/00898
A A61 A61B2018/00994
A A61 A61B2018/0262
A A61 A61B2018/0293

Field of Art

Medical device technologies for cryogenic tissue treatment, specifically dermatological interventions involving precision cooling and temperature regulation systems

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or medical device designer with expertise in thermal control systems, temperature sensing technologies, minimally invasive medical procedures, and advanced electronic integration techniques

Obviousness Rationale

A PHOSITA would recognize that integrating contemporary digital technologies like AI, IoT, and blockchain into existing cryogenic medical device architectures represents a predictable technological evolution. The fundamental cryogenic needle mechanism remains consistent with the source patent, while the proposed variations merely introduce well-known computational and sensing technologies to enhance existing functionality. These technological additions provide incremental improvements that would be obvious to a skilled practitioner seeking to optimize medical device performance and data management.

Obvious Combinations & Variations

Source Patent Element
Coolant supply system regulated by a valve for controlling cooling zone size
PTD Variation
AI-powered temperature control module adjusting coolant flow based on real-time temperature data
Obviousness Reasoning
Implementing adaptive control algorithms is a known technique for improving thermal regulation, representing a predictable application of machine learning to existing temperature control systems
Source Patent Element
Needle probe with temperature monitoring capabilities
PTD Variation
IoT-enabled temperature sensing module transmitting real-time data to remote monitoring systems
Obviousness Reasoning
Extending local temperature sensing to networked monitoring is a standard technological progression in medical device design, utilizing established communication protocols
Source Patent Element
Method for cryogenically treating target tissue with precise temperature control
PTD Variation
Blockchain-based secure data storage system for treatment documentation
Obviousness Reasoning
Implementing secure, immutable record-keeping is a predictable solution for medical data management, representing an obvious technological enhancement
Source Patent Element
Thermal regulation of cryogenic needle probe
PTD Variation
New material-based thermal insulation system maintaining consistent temperature profile
Obviousness Reasoning
Exploring advanced materials for improved thermal performance is a routine design optimization approach in medical device engineering
35 U.S.C. § 103 Summary: Based on US Patent 11857239's disclosure of cryogenic needle technologies, the present publication demonstrates that integrating AI, IoT, blockchain, and advanced materials represents an obvious technological progression for those skilled in medical device design. The variations disclosed herein would be considered routine engineering adaptations that do not rise to the level of non-obvious innovation, thereby establishing robust prior art against potential future patent claims in this technological domain.

Original Patent Information

Patent NumberUS 11,857,239
TitleCryogenic needle with freeze zone regulation
Assignee(s)Pacira CryoTech, Inc.